Title:
|
DEFINING OPTIMAL IMMUNOTHERAPIES FOR TYPE 1 DIABETES
|
By: |
Novartis Foundation |
Format: |
Hardback |
List price:
|
£157.95 |
Our price: |
£142.16 |
Discount: |
|
You save:
|
£15.79 |
|
|
|
|
ISBN 10: |
0470723254 |
ISBN 13: |
9780470723258 |
Availability: |
Usually dispatched within 1-3 weeks.
Delivery
rates
|
Stock: |
Currently 0 available |
Publisher: |
JOHN WILEY AND SONS LTD |
Pub. date: |
13 June, 2008 |
Series: |
Novartis Foundation Symposia 292 |
Pages: |
222 |
Description: |
* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D). |
Synopsis: |
* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).* Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.* The book integrates information from human and animal studies.* The book considers T1D within the broader context of autoimmune disease.* The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure. |
Illustrations: |
Illustrations |
Publication: |
US |
Imprint: |
Wiley-Blackwell |
Returns: |
Returnable |